Prevalence of Ever-Diagnosed ASD 2.79 Percent in U.S. Children

The prevalence of ever-diagnosed autism spectrum disorder (ASD) is 2.79 percent in the United States, with state-level variations in prevalence, according to a study published online Dec. 3 in JAMA Pediatrics.
Guifeng Xu, M.D., from the University of Iowa in Iowa City, and colleagues used cross-sectional data from the 2016 National Survey of Children's Health to estimate the prevalence and treatment patterns of ASD among young children. Data were included for 43,032 children aged 3 to 17 years and were obtained from questionnaires completed by a parent or guardian.
The researchers found the weighted prevalence of ever-diagnosed and current ASD was 2.79 and 2.50 percent, respectively. There was variation in the state-level prevalence of ever-diagnosed ASD from 1.54 percent in Texas to 4.88 percent in Florida. About 70 percent of children with current ASD were treated nationally: 43.3, 6.9, and 20.3 percent received behavioral treatment only, medication only, and both behavioral and medication treatments, respectively; 29.5 percent did not receive behavioral or medication treatment.
"Continued monitoring of the prevalence and treatment of ASD is warranted," the authors write. "Future research and policy efforts are critically needed to understand and address the barriers for children with ASD to receive appropriate treatments."
2026-08-31
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Celanese to Close Acetate Tow Plant in Lanaken, Belgium by 2026
-
USDA Puts Fresh Money Into Local Food Markets
-
Qatar LNG Hit by Attack: 17% Export Capacity Lost, $20 Billion Wiped Out
-
Laboratoire PYC showcases its collagen-driven nutricosmetic innovations
-
Kemira to Acquire SIDRA Wasserchemie, Expanding European Water Treatment Footprint
-
Vietnam Drives ASEAN Towards a Modern Economy
-
Amazon Turns Lilly’s Weight-Loss Pill Into a Retail Logistics Play
-
“The 40-Year Ethylene Giant Collapses”: ExxonMobil’s Premature Shutdown Is Not Just Scotland’s Tragedy—It’s the Twilight Elegy of European Industrial Civilization
-
Japan Tightens Additive Use Standards
-
India’s Tariff Cuts Could Lower Agrochemical Costs
Recommend Reading
-
China Moves Lycopene Toward Filing-Based Health Food Management
-
Brazil Rewrites the Supplement Rulebook
-
March Brought a Faster Global Food Rule Cycle
-
The Chemical Market Is No Longer Just Raising Prices — It Has Started Stopping Quotations
-
Japan’s Three Major Chemical Companies Join Forces to Weather Challenges in the Plastics Industry
-
Strong Costs Keep PP Prices Stable Ahead of the Holiday
-
Vanillin: Properties, Uses, and Safety
-
Supporting Each Other | ECHEMI Employees Voluntarily Raise Funds for Flood Relief in Southern Thailand
-
Weak demand for downstream formic acid in China leads to fluctuating prices
-
Urea Market Trends in February Show a Strong, Rising Trend